Efficacy of gokshurguggulu vati in the management of high blood sugar level in diabetes patients in comparison with the tablet metformin

A randomised controlled clinical trial to study efficacy of gokshurguggulu vati with tablet metformin in the management of madhumeha with special reference to hyperglycaemia in diabetes mellitus type 2 - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093176

Enrollment

Registered

2025-08-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: History of Diabetes mellitus less than 3 years. Patients presenting with Prakarsha mutrata(Increased frequency of urination)Prabhut mutrata(polyuria)Aavila mutrata(Turbid urine). Random blood sugar level should be below 300 mg/dl fasting blood sugar level below 200 mg/dl post prandial sugar level below 300 mg/dl

Exclusion criteria

Exclusion criteria: lusion criteria:- 1. Patients of Diabetes Mellitus Type-1 2. Patients having history of raised Blood Sugar Level more than 3 years . 2. Patients of Diabetes Mellitus Type-2 other than Hyperglycemia. 3. Patient will be excluded below age 39 years and above 71 years old. 4. Patient suffering from Chronic kidney disease, HIV, Tuberculosis, Tumors. 5. Macrovascular (CAD,PVD,CVD) diseases. 6. Pregnancy induced diabetes mellitus 7. Patients having complications like Diabetic ketoacidosis, Retinopathy, Neuropathy,Nephropathy, Gangrene, etc. 8. Juvenile Diabetes Mellitus, Diabetes insipidus. 9. Patients suffering from congenital, chronic systemic illness, Chemotherapy and radiation therapy of CA patients. 10. Surgical and traumatically injured patients. 11. Congenital anomalies of pancreas. Patient who will discontinue the treatment. 12. Patient unwilling to take the treatment during study. 13. Patient shows any type of adverse effect. 14. Patient who do not attend follow ups regularly.

Design outcomes

Primary

Measure	Time frame
Gokshurguggulu vati is significantly effective in MadhumehaTimepoint: Initial assessment at 0 day Follow up 7th 14th 21st and 30th day Final assessment at 30th day	—

Secondary

Measure	Time frame
Gokshurguggulu vati is not significantly effective in Madhumeha As compared to tab Metformin 500 mgTimepoint: Initial assessment at 0 day Follow up 7th 14th 21st and 30th day Final assessment at 30th day	—

Countries

India

Contacts

Public ContactDr Swapnali Dattatray Talap

Late kedari redekar ayurvedic mahavidyalaya P G training and research centre gadhinglaj kolhapur

drjayantpatil07@gmail.com8600660485

Outcome results